Desipramine and cutaneous reactions in pediatric outpatients.
The association of adverse cutaneous effects with administration of the tricyclic antidepressant drug desipramine was systematically reviewed in a clinic population of 205 child psychiatry outpatients over a 3-year period. Transient maculopapular rashes developed in 12 children and adolescents treated with desipramine. The rashes had a benign course, disappearing completely in 2 to 7 days, and were not associated with clinical or chemical hepatitis or any other physical symptoms.
Biederman
J
J
Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114.
Gonzalez
E
E
Bronstein
B
B
De Monaco
H
H
Wright
V
V
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000553:Ambulatory Care; D001008:Anxiety Disorders / Q000188:drug therapy; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002648:Child; D003866:Depressive Disorder / Q000188:drug therapy; D003891:Desipramine / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008404:Massachusetts; D012189:Retrospective Studies
D003891:Desipramine